Cardinal Health Analyst Ratings
Argus Research Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $125
Argus Research Reaffirms Their Buy Rating on Cardinal Health (CAH)
Jefferies Adjusts Price Target on Cardinal Health to $110 From $105
Cardinal Health Analyst Ratings
JPMorgan Adjusts Price Target on Cardinal Health to $123 From $111, Maintains Neutral Rating
Cardinal Health Analyst Ratings
Deutsche Bank Maintains Hold on Cardinal Health, Raises Price Target to $119
A Quick Look at Today's Ratings for Cardinal Health(CAH.US), With a Forecast Between $101 to $137
Cardinal Health: A Balanced Outlook With a Hold Rating Amidst Mixed Results and Growth Efforts
Deutsche Bank Raises Cardinal Health Price Target to $119 From $115
A Quick Look at Today's Ratings for Cardinal Health(CAH.US), With a Forecast Between $101 to $119
Cardinal Health Analyst Ratings
Baird Maintains Outperform on Cardinal Health, Raises Price Target to $137
Evercore ISI Adjusts Price Target on Cardinal Health to $105 From $115
Analysts Conflicted on These Healthcare Names: Arcutis Biotherapeutics (ARQT), Gilead Sciences (GILD) and Cardinal Health (CAH)
Cardinal Health: A Cautious Hold Amidst Mixed Results and Moderate FY25 Optimism
Analysts Offer Insights on Healthcare Companies: Evotec AG (EVO), Medtronic (MDT) and Cardinal Health (CAH)
Barclays Keeps Their Buy Rating on Cardinal Health (CAH)
Cardinal Health: A Hold Rating With Moderate Growth Prospects